378 related articles for article (PubMed ID: 38791160)
1. The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging.
Bocheva G; Bakalov D; Iliev P; Tafradjiiska-Hadjiolova R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791160
[TBL] [Abstract][Full Text] [Related]
2. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
Pandi-Perumal SR; BaHammam AS; Brown GM; Spence DW; Bharti VK; Kaur C; Hardeland R; Cardinali DP
Neurotox Res; 2013 Apr; 23(3):267-300. PubMed ID: 22739839
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
[TBL] [Abstract][Full Text] [Related]
4. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
[TBL] [Abstract][Full Text] [Related]
5. The melatonin metabolite N1-acetyl-5-methoxykynuramine facilitates long-term object memory in young and aging mice.
Iwashita H; Matsumoto Y; Maruyama Y; Watanabe K; Chiba A; Hattori A
J Pineal Res; 2021 Jan; 70(1):e12703. PubMed ID: 33125735
[TBL] [Abstract][Full Text] [Related]
6. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?
Tan DX; Manchester LC; Terron MP; Flores LJ; Reiter RJ
J Pineal Res; 2007 Jan; 42(1):28-42. PubMed ID: 17198536
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
[TBL] [Abstract][Full Text] [Related]
8. N1-Acetyl-5-methoxykynuramine, which decreases in the hippocampus with aging, improves long-term memory via CaMKII/CREB phosphorylation.
Watanabe K; Maruyama Y; Iwashita H; Kato H; Hirayama J; Hattori A
J Pineal Res; 2024 Jan; 76(1):e12934. PubMed ID: 38241676
[TBL] [Abstract][Full Text] [Related]
9. Melatonin: new places in therapy.
Maharaj DS; Glass BD; Daya S
Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and the aging brain.
Bondy SC; Sharman EH
Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
[TBL] [Abstract][Full Text] [Related]
11. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
[TBL] [Abstract][Full Text] [Related]
14. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Chen D; Zhang T; Lee TH
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
[TBL] [Abstract][Full Text] [Related]
15. Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles.
Martinez GR; Almeida EA; Klitzke CF; Onuki J; Prado FM; Medeiros MH; Di Mascio P
Endocrine; 2005 Jul; 27(2):111-8. PubMed ID: 16217124
[TBL] [Abstract][Full Text] [Related]
16. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats.
Rozov SV; Filatova EV; Orlov AA; Volkova AV; Zhloba AR; Blashko EL; Pozdeyev NV
J Pineal Res; 2003 Nov; 35(4):245-50. PubMed ID: 14521629
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin.
León J; Escames G; Rodríguez MI; López LC; Tapias V; Entrena A; Camacho E; Carrión MD; Gallo MA; Espinosa A; Tan DX; Reiter RJ; Acuña-Castroviejo D
J Neurochem; 2006 Sep; 98(6):2023-33. PubMed ID: 16945113
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite.
Harthé C; Claudy D; Déchaud H; Vivien-Roels B; Pévet P; Claustrat B
Life Sci; 2003 Aug; 73(12):1587-97. PubMed ID: 12865098
[TBL] [Abstract][Full Text] [Related]
19. Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.
Melhuish Beaupre LM; Brown GM; Gonçalves VF; Kennedy JL
Transl Psychiatry; 2021 Jun; 11(1):339. PubMed ID: 34078880
[TBL] [Abstract][Full Text] [Related]
20. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.
Galano A; Tan DX; Reiter RJ
J Pineal Res; 2013 Apr; 54(3):245-57. PubMed ID: 22998574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
